Skip to content

Drug interactions

Secobarbital + Tucatinib

Severity: Major

Secobarbital and Tucatinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Secobarbital may induce CYP3A4 and CYP2C8, enzymes that contribute to tucatinib metabolism, and thereby lower its concentrations. Reduced exposure may weaken efficacy in HER2-positive breast cancer.

What this interaction means in plain words

Secobarbital and Tucatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Secobarbital belongs to Central Nervous System; Tucatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Barbiturate induction of CYP3A4 and CYP2C8 increases tucatinib clearance.

What to do

Avoid strong CYP3A4 or CYP2C8 inducers with tucatinib and use an alternative sedative. Monitor for reduced response if unavoidable.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Secobarbital and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Secobarbital with Tucatinib?

MediHelp rates the interaction as major. Secobarbital and Tucatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Secobarbital may induce CYP3A4 and CYP2C8, enzymes that contribute to tucatinib metabolism, and thereby lower its concentrations. Reduced exposure may weaken efficacy in HER2-positive breast cancer.

How serious is the interaction between Secobarbital and Tucatinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid strong CYP3A4 or CYP2C8 inducers with tucatinib and use an alternative sedative. Monitor for reduced response if unavoidable.

What other medicines interact with Secobarbital?

MediHelp also lists interactions of Secobarbital with, for example, Calcium / magnesium / potassium / sodium oxybates, Doravirine, Elbasvir / grazoprevir. The full list is on the Secobarbital page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in